China approves sales of first domestically developed 13-valent pneumonia vaccine
China approves sales of first domestically developed 13-valent pneumonia vaccine
Reuters: Health
China has approved a pneumonia vaccine developed by domestic drugmaker Walvax Biotechnology, its National Medical Products Administration said in a notice on Tuesday, offering an alternative to Pfizer's market-dominating Prevnar 13.
Reuters: Health
China has approved a pneumonia vaccine developed by domestic drugmaker Walvax Biotechnology, its National Medical Products Administration said in a notice on Tuesday, offering an alternative to Pfizer's market-dominating Prevnar 13.
Comments
Post a Comment